A48.51 Infant botulism

Name of the Condition

• Infant botulism

Summary

Infant botulism is a rare but serious condition caused by the ingestion of Clostridium botulinum spores, which colonize the infant’s intestinal tract and produce botulinum neurotoxin. This toxin disrupts neuromuscular transmission, leading to flaccid paralysis and systemic effects. The condition primarily affects infants under 1 year of age and requires prompt recognition and supportive care.

Causes

Infant botulism occurs when infants ingest Clostridium botulinum spores, often from contaminated honey, soil, or dust. The spores germinate in the immature gut, producing neurotoxin that is absorbed into the bloodstream. Unlike foodborne botulism, the toxin is endogenously produced rather than preformed in food.

Risk Factors

• Age under 1 year (peak incidence 2–4 months)
• Ingestion of honey or corn syrup (common sources of spores)
• Exposure to soil or dust containing C. botulinum spores
• Immature gastrointestinal flora that allows spore colonization
• Rural or agricultural environments with increased spore exposure

Symptoms

• Floppy or weak muscle tone (hypotonia)
• Poor feeding, weak suck, or difficulty swallowing
• Lethargy or decreased activity
• Constipation (often an early sign)
• Weak cry or respiratory distress
• Asymmetric facial weakness or ptosis
• Loss of head control or delayed milestones

Diagnosis

Diagnosis is based on clinical presentation (e.g., hypotonia, constipation) and confirmed by detecting botulinum toxin or C. botulinum in stool samples. Electromyography (EMG) may show characteristic findings, and blood tests rule out other causes. Imaging or lumbar puncture is typically not required.

Treatment Options

• Supportive care, including respiratory support (ventilation if needed)
• Antitoxin therapy (botulism immune globulin) to neutralize circulating toxin
• Nasogastric or parenteral nutrition to maintain hydration and nutrition
• Monitoring for complications (e.g., respiratory failure)
• Avoidance of honey or spore-containing products in infants

Prognosis and Follow-Up

Most infants recover fully with prompt treatment, though recovery may take weeks to months. Follow-up includes monitoring for residual weakness, developmental delays, or recurrent symptoms. Long-term outcomes are generally favorable with appropriate care.

Complications

• Respiratory failure requiring prolonged ventilation
• Pneumonia or other secondary infections
• Feeding difficulties or aspiration
• Delayed motor development
• Rarely, death (especially without timely intervention)

Lifestyle & Prevention

• Avoid giving honey or products containing honey to infants under 1 year
• Practice good hand hygiene when handling infants
• Minimize exposure to soil or dust in infant environments
• Ensure safe food preparation and storage to reduce spore contamination

When to Seek Professional Help

Seek immediate medical attention if an infant shows signs of hypotonia, poor feeding, lethargy, or respiratory distress. Early intervention improves outcomes and reduces complications.

Tips for Medical Coders

Use code A48.51 for infant botulism. Document the clinical presentation (e.g., hypotonia, constipation) and confirmatory testing (e.g., stool toxin assay) to support the diagnosis. Ensure the code is not used for other botulism types (e.g., foodborne or wound botulism) and aligns with the infant’s age and exposure history.